Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
1(20.0%)
Phase 2
1(20.0%)
5Total
N/A(3)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02993211Not ApplicableCompleted

Transurethral En Bloc Versus Standard Resection of Bladder Tumour

Role: collaborator

NCT03814369Not ApplicableCompleted

AmplifEYE Colonoscopy vs Standard Colonoscopy

Role: collaborator

NCT02795390Phase 2Completed

Clinical Trial on Palliative Cancer Patients With Constipation

Role: collaborator

NCT03038490Not ApplicableUnknown

The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers

Role: lead

NCT01315977Phase 1Unknown

Dietary Antioxidants, Redox Tone and Health Promotion: an Orthomolecular Study of Interactions

Role: collaborator

All 5 trials loaded